Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

COVID-19

Free Subscription Articles published in J Thorac Oncol Retrieve available abstracts of 46 articles: HTML format

Single Articles

June 2023
1. PIETROLUONGO E, De Placido P, Tortora M, Martinelli C, et al
   Impaired seroconversion after SARS-CoV-2 mRNA vaccine in patients with thymic epithelial tumors.
   J Thorac Oncol. 2023 Jun 28:S1556-0864(23)00634.
   PubMed     Abstract available
   
   
   June 2022
2. HIBINO M, Uryu K, Takeda T, Kunimatsu Y, et al
   Safety and Immunogenicity of mRNA Vaccines Against Severe Acute Respiratory Syndrome Coronavirus 2 in Patients With Lung Cancer Receiving Immune Checkpoint Inhibitors: A Multicenter Observational Study in Japan.
   J Thorac Oncol. 2022 Jun 22. pii: S1556-0864(22)00295.
   PubMed     Abstract available
   
   
   May 2022
3. ZHANG C, Wu YL, Zhong WZ
   New Normal for Lung Cancer Clinical Trials Under Coronavirus Disease 2019.
   J Thorac Oncol. 2022;17:588-591.
   PubMed    
   
   
   February 2022
4. SMELTZER MP, Scagliotti GV, Wakelee HA, Mitsudomi T, et al
   International Association for the Study of Lung Cancer (IASLC) Study of the Impact of COVID-19 on International Lung Cancer Clinical Trials.
   J Thorac Oncol. 2022 Feb 15. pii: S1556-0864(22)00086.
   PubMed     Abstract available
   
   
   January 2022
5. WHISENANT JG, Baena J, Cortellini A, Huang LC, et al
   A definitive prognostication system for patients with thoracic malignancies diagnosed with COVID-19: an update from the TERAVOLT registry.
   J Thorac Oncol. 2022 Jan 24. pii: S1556-0864(22)00033.
   PubMed     Abstract available
   
   
   
6. MASAGO K, Fujita S
   Effect of Coronavirus Disease 2019 Vaccine-Related Lymphadenopathy on Lung Cancer Treatment.
   J Thorac Oncol. 2022;17:16-18.
   PubMed    
   
   
   December 2021
7. HUBER RM, Cavic M, Kerpel-Fronius A, Viola L, et al
   Lung Cancer Screening Considerations During Respiratory Infection Outbreaks, Epidemics or Pandemics: An IASLC Early Detection and Screening Committee Report.
   J Thorac Oncol. 2021 Dec 2. pii: S1556-0864(21)03326.
   PubMed     Abstract available
   
   
   November 2021
8. ROLFO C, Meshulami N, Russo A, Krammer F, et al
   Lung Cancer and SARS-CoV-2 infection: Identifying important knowledge gaps for investigation.
   J Thorac Oncol. 2021 Nov 10. pii: S1556-0864(21)03309.
   PubMed     Abstract available
   
   
   
9. GOUNANT V, Ferre VM, Soussi G, Charpentier C, et al
   Efficacy of SARS-CoV-2 vaccine in thoracic cancer patients: a prospective study supporting a third dose in patients with minimal serologic response after two vaccine doses.
   J Thorac Oncol. 2021 Nov 2. pii: S1556-0864(21)03286.
   PubMed     Abstract available
   
   
   
10. YANG C, Li Y, Xiao SY
    Do We Really Understand the Relationship Between Expression of ACE2 and Coronavirus Disease 2019 Lung Pathophysiology?
    J Thorac Oncol. 2021;16:1785-1787.
    PubMed    
    
    
    September 2021
11. NISHINO M, Hatabu H, Ricciuti B, Vaz V, et al
    Brief Report Axillary lymphadenopathy after COVID-19 vaccinations in patients with thoracic malignancy: Incidence, predisposing factors, and imaging characteristics.
    J Thorac Oncol. 2021 Sep 7. pii: S1556-0864(21)03184.
    PubMed     Abstract available
    
    
    July 2021
12. STEWART CA, Gay CM, Ramkumar K, Cargill KR, et al
    Lung cancer models reveal SARS-CoV-2-induced EMT contributes to COVID-19 pathophysiology.
    J Thorac Oncol. 2021 Jul 15. pii: S1556-0864(21)02294.
    PubMed     Abstract available
    
    
    June 2021
13. WARREN GW, Lim VS, Chowdhary M, Marwaha G, et al
    Brief Report: New Pulmonary Infiltrates Observed on Computed Tomography Based Image Guidance for Radiotherapy Warrant Diagnostic Workup for COVID-19.
    J Thorac Oncol. 2021 Jun 21. pii: S1556-0864(21)02232.
    PubMed     Abstract available
    
    
    January 2021
14. CARBONE M, Lednicky J, Xiao SY, Venditti M, et al
    Coronavirus Infectious Disease Epidemic (COVID-19): where we are, what can be done and hope for.
    J Thorac Oncol. 2021 Jan 7. pii: S1556-0864(20)31140.
    PubMed     Abstract available
    
    
    December 2020
15. ROSSI G, Caruso D, Stella F, Davoli F, et al
    Histologic Confounding Findings in Coronavirus disease 2019 (COVID-19) Pathology.
    J Thorac Oncol. 2020;15:e192-e193.
    PubMed    
    
    
    
16. CAI Y, Kuang D, Zhang N
    Response to Letter to the Editor.
    J Thorac Oncol. 2020;15:e193-e194.
    PubMed    
    
    
    November 2020
17. BAKHRIBAH H, Alfayea T
    Immunotherapy and Coronavirus Disease 2019: Challenges and Possibilities.
    J Thorac Oncol. 2020;15:1709-1710.
    PubMed    
    
    
    
18. RICE SJ, Hyland V, Behera M, Ramalingam SS, et al
    Guidance on the Clinical Management of Electronic Cigarette or Vaping-Associated Lung Injury.
    J Thorac Oncol. 2020;15:1727-1737.
    PubMed     Abstract available
    
    
    October 2020
19. KIDANE B, Levin DP
    Identification and Resolution of Asymptomatic COVID-19 Pneumonitis and Colitis: Serial Assessment of Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography for Evaluation of Lung Cancer.
    J Thorac Oncol. 2020 Oct 5. pii: S1556-0864(20)30725.
    PubMed    
    
    
    
20. SEITLINGER J, Banga Nkomo D, Streit A, Stasiak F, et al
    Letter to the Editor Concerning the Article From Cai et al. Focusing on Coronavirus Disease 2019 Impact on Lung Cancer Resection, Published in June 2020.
    J Thorac Oncol. 2020;15:e172-e173.
    PubMed    
    
    
    
21. CAI Y, Gao Y, Zhang N
    Response to Letter to the Editor.
    J Thorac Oncol. 2020;15:e173-e174.
    PubMed    
    
    
    August 2020
22. CALABRESE F, Fortarezza F, Giraudo C, Pezzuto F, et al
    Two sorts of microthrombi in a COVID-19 patient with lung cancer.
    J Thorac Oncol. 2020 Aug 28. pii: S1556-0864(20)30668.
    PubMed    
    
    
    July 2020
23. ROLFO C, Cardona AF, Ruiz-Patino A, Ariza S, et al
    Atypical skin manifestations during immune checkpoint blockage in COVID19-infected lung cancer patients.
    J Thorac Oncol. 2020 Jul 9. pii: S1556-0864(20)30543.
    PubMed     Abstract available
    
    
    June 2020
24. MCGINNIS GJ, Ning MS, Nitsch PL, O'Reilly MS, et al
    Rapid Detection of Asymptomatic Coronavirus Disease 2019 by Computed Tomography Image Guidance for Stereotactic Ablative Radiotherapy.
    J Thorac Oncol. 2020;15:1085-1087.
    PubMed    
    
    
    May 2020
25. OUYANG W, Hu J, Zhang H, Xie C, et al
    The Management of Patients With Lung Cancer During the Outbreak of Coronavirus Disease 2019.
    J Thorac Oncol. 2020 May 23. pii: S1556-0864(20)30385.
    PubMed    
    
    
    
26. DINGEMANS AC, Soo RA, Jazieh AR, Rice SJ, et al
    Treatment guidance for lung cancer patients during the COVID-19 pandemic.
    J Thorac Oncol. 2020 May 13. pii: S1556-0864(20)30382.
    PubMed     Abstract available
    
    
    
27. ZHU J, Zhang Y, Gao XH, Xi EP, et al
    COVID-19 or Lung Cancer: A differential diagnostic experience and management model from Wuhan.
    J Thorac Oncol. 2020 May 6. pii: S1556-0864(20)30377.
    PubMed    
    
    
    
28. CHANG HL, Chen YH, Yang CJ
    Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI)-Associated Interstitial Lung Disease During the COVID-19 Pandemic.
    J Thorac Oncol. 2020 May 5. pii: S1556-0864(20)30376.
    PubMed    
    
    
    
29. LEE JC, Blazak JK
    The Use of Positron Emission Tomography in Coronavirus Disease 2019 Cases.
    J Thorac Oncol. 2020 May 5. pii: S1556-0864(20)30374.
    PubMed    
    
    
    
30. TIAN S, Xiao SY
    Pathology of 2019 Novel Coronavirus Pneumonia: A Dynamic Disease Process.
    J Thorac Oncol. 2020;15:e67-e68.
    PubMed    
    
    
    
31. JOOB B, Wiwanitkit V
    Pulmonary Pathology of Early Phase 2019 Novel Coronavirus Pneumonia.
    J Thorac Oncol. 2020;15:e67.
    PubMed    
    
    
    
32. CARBONE M, Green JB, Bucci EM, Lednicky JA, et al
    Coronaviruses: Facts, Myths, and Hypotheses.
    J Thorac Oncol. 2020;15:675-678.
    PubMed    
    
    
    April 2020
33. KUMAR S, Chmura S, Robinson C, Lin SH, et al
    Alternative Multidisciplinary Management Options for Locally Advanced Non-Small Cell Lung Cancer During the COVID-19 Global Pandemic.
    J Thorac Oncol. 2020 Apr 28. pii: S1556-0864(20)30331.
    PubMed     Abstract available
    
    
    
34. CAFAROTTI S
    SARS-COV2 INFECTION AND LUNG CANCER PATIENTS: the potential role of IL17 target therapy.
    J Thorac Oncol. 2020 Apr 27. pii: S1556-0864(20)30330.
    PubMed     Abstract available
    
    
    
35. SANZ-SANTOS J, Rami-Porta R, Call S
    Lessons already learnt from the Covid-19 pandemic.
    J Thorac Oncol. 2020 Apr 22. pii: S1556-0864(20)30326.
    PubMed    
    
    
    
36. WARREN G, Adjei AA
    A CALL FOR RAPID SUBMISSION OF DATA FOR AGGREGATE REVIEW: Can daily radiotherapy imaging be used as a potential screen for COVID-19?
    J Thorac Oncol. 2020 Apr 21. pii: S1556-0864(20)30318.
    PubMed    
    
    
    
37. OUYANG W, Yu J, Zhang J, Xie C, et al
    Alert to Potential Contagiousness: A Case of Lung Cancer with Asymptomatic SARS-CoV-2 Infection.
    J Thorac Oncol. 2020 Apr 16. pii: S1556-0864(20)30300.
    PubMed    
    
    
    
38. CAFAROTTI S, Patella M
    LUNG CANCER SURGICAL MANAGEMENT DURING THE OUTBREAK OF COVID-19.
    J Thorac Oncol. 2020 Apr 11. pii: S1556-0864(20)30291.
    PubMed    
    
    
    
39. CAI Y, Hao Z, Gao Y, Ping W, et al
    COVID-19 in the perioperative period of lung resection: a brief report from a single thoracic surgery department in Wuhan, China.
    J Thorac Oncol. 2020 Apr 11. pii: S1556-0864(20)30298.
    PubMed     Abstract available
    
    
    
40. RUSSANO M, Citarella F, Vincenzi B, Tonini G, et al
    COVID-19 or Lung Cancer: what should we treat?
    J Thorac Oncol. 2020 Apr 10. pii: S1556-0864(20)30294.
    PubMed    
    
    
    
41. SUPPLI MH, Riisgaard de Blanck S, Elgaard T, Josipovic M, et al
    Early appearance of COVID-19 associated pulmonary infiltrates during daily radiotherapy imaging for lung cancer.
    J Thorac Oncol. 2020 Apr 10. pii: S1556-0864(20)30299.
    PubMed    
    
    
    March 2020
42. POLVERARI G, Arena V, Ceci F, Pelosi E, et al
    (18)F-FDG uptake in Asymptomatic SARS-CoV-2 (COVID-19) patient, referred to PET/CT for Non-Small Cells Lung Cancer restaging.
    J Thorac Oncol. 2020 Mar 31. pii: S1556-0864(20)30286.
    PubMed    
    
    
    
43. BONOMI L, Ghilardi L, Arnoldi E, Tondini CA, et al
    A rapid fatal evolution of Coronavirus Disease-19 (COVID-19) in an advanced lung cancer patient with a long time response to nivolumab.
    J Thorac Oncol. 2020 Mar 31. pii: S1556-0864(20)30285.
    PubMed    
    
    
    
44. GIANI M, Seminati D, Lucchini A, Foti G, et al
    Exuberant plasmocytosis in bronchoalveolar lavage of the first patient requiring Extracorporeal Membrane Oxygenation for SARS-CoV-2 in Europe.
    J Thorac Oncol. 2020 Mar 16. pii: S1556-0864(20)30201.
    PubMed    
    
    
    
45. ZHANG H, Huang Y, Xie C
    The Treatment and Outcome of a Lung Cancer Patient Infected with SARS-CoV-2.
    J Thorac Oncol. 2020 Mar 5. pii: S1556-0864(20)30191.
    PubMed    
    
    
    February 2020
46. TIAN S, Hu W, Niu L, Liu H, et al
    Pulmonary pathology of early phase 2019 novel coronavirus (COVID-19) pneumonia in two patients with lung cancer.
    J Thorac Oncol. 2020 Feb 27. pii: S1556-0864(20)30132.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO COVID-19 is free of charge.